Shares of Illumina Inc. ILMN shed 1.51% to $100.24 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 and Dow ...

Carl Icahn’s Icahn Capital disclosed in an SEC filing its holdings as of December 31, 2024. The fund increased its stakes in two holdings, ...

Fintel reports that on February 10, 2025, Barclays downgraded their outlook for Illumina (NasdaqGS:ILMN) from Equal-Weight to ...

CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted significant advancements ...

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Follow along for live updates on stocks, bonds and markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...

Xi’s government swung back almost immediately after US levies came into force, dashing hopes that Beijing would reach a deal ...

China retaliated to Donald Trump’s opening trade war tariffs by targeting a handful of American companies and slapping levies ...

Shares of Illumina Inc. ILMN shed 1.24% to $131.10 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.76% to 5,994.57 and Dow ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Investing.com - The personal consumption expenditures (PCE) price index accelerated slightly in December, in line with estimates, while the pace of consumer spending unexpectedly rose ...